4[6]WILLIAM L,ROBERTS,RACHEL S,et al.Evaluation of four automated high-sensitivity C-reactive protein methods:implications for clinical and epidemiological applications[J].Clin Chem,2000,4:461-468.
5[8]TSUTAMOTO T,WADA A,MAEDA K.Angiotensin 2 type 1 receptor antagonist decrease plasma leveis of tumor necrosis factor alpha,interleukin 6 and stable adhesion molecules in patients with chronic heart failure[J].J Am Coll Cardiol,2000,35:714-716.
6[9]LEYVA F,ANKER S D,GODSLAND I F,et al.Uric acid in chronic heart failure:a marker of chronic inflammation[J].Eur Heart J,1998,9(12):1814-1822.
7[1]MARCEIO E,OCHIAI A,ANTONIO C P,et al.Uric acid renal excretion and renal insufficiency in decompens aged severe heart failure[J].The European Journal of Heart Failure,2005,7(2):468-474.
8[4]FANG J,ALDERMAN M H,FERMEN H.Serum uric acid and cardiovascular mortality the NHANES.epidemiologic follow-up study,1971-1992[J].The Journal of American Medical Association,2000,283(18):2404-2410.
9[5]FERRANTI S D,RIFAI N.C-reactive protein and cardiovascular disease:a review of risk prediction and intervention[J].Clin Chim Acta,2002,317:1-15.
10YEUN J Y ,LEVINE R A ,MANTADILOK N , et al. C - reactive protein predicts all cause and cardiovascular mortality in hemodialysis patients [J].Am J Kidney Dis , 2000,35 ( 3 ) :469-476.
